Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biometals ; 30(3): 379-392, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28409296

RESUMO

Complexes [Ag(HCrPh)2]NO3·2H2O (1) and [Ag(HCrpClPh)2]NO3 (2) were obtained with 3-formyl-6-methylchromone-phenyl hydrazone (HCrPh, HL1) and 3-formyl-6-methylchromone-para-chloro-phenyl hydrazone (HCrpClPh, HL2). Although the hydrazones were inactive, upon coordination to silver(I) antifungal activity significantly improved against several Candida strains. Complexes (1-2) revealed to be more active than silver nitrate, silver sulfadiazine and the reference drug nystatin against Candida parapsilosis. The cytotoxic activities of the hydrazones and their silver(I) complexes were evaluated in comparison with cisplatin on B16F10 (metastatic melanoma) and Melan-a (non-tumorigenic melanocyte) cells. The hydrazones showed low cytotoxicity against B16F10 cells, reducing only about 20% of cell viability at the concentration of 10 µM. Upon coordination to silver(I) the cytotoxic effect did not appreciably change in complex (1) while complex (2) proved to be as cytotoxic as cisplatin and much more cytotoxic than both the free ligand and silver nitrate at 1 µM. Both complexes (1) and (2) were less active than cisplatin on non-malignant Melan-a cells, indicating that these compounds might promote less damage on normal cells.


Assuntos
Antifúngicos/farmacologia , Candida/efeitos dos fármacos , Cromonas/farmacologia , Hidrazonas/farmacologia , Compostos Organometálicos/farmacologia , Prata/farmacologia , Animais , Antifúngicos/síntese química , Antifúngicos/química , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Cromonas/química , Cisplatino/farmacologia , Cristalografia por Raios X , Relação Dose-Resposta a Droga , Hidrazonas/química , Melanócitos/citologia , Melanócitos/efeitos dos fármacos , Melanoma/patologia , Camundongos , Testes de Sensibilidade Microbiana , Modelos Moleculares , Estrutura Molecular , Compostos Organometálicos/síntese química , Compostos Organometálicos/química , Prata/química , Relação Estrutura-Atividade
2.
Biometals ; 29(1): 39-52, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26582127

RESUMO

Copper(II) complexes [Cu(H2O)2 (L1)(phen)](ClO4) (1) and [Cu(H2O)(L2)(phen)](ClO4) (2) (HL1 = naringenin; HL2 = hesperetin) were obtained, in which an anionic flavonoid ligand is attached to the metal center along with 1,10-phenanthroline (phen) as co-ligand. Complexes (1) and (2) were assayed for their cytotoxic activity against A549 lung carcinoma and against normal lung fibroblasts (LL-24) and human umbilical vein endothelial cells (HUVEC). We found IC50 = 16.42 µM (1) and IC50 = 5.82 µM (2) against A549 tumor cells. Complexes (1) and (2) exhibited slight specificity, being more cytotoxic against malignant than against non-malignant cells. 1 and 2 induced apoptosis on A549 cells in a mitochondria-independent pathway, and showed antioxidant activity. The antioxidant effect of the complexes could possibly improve their apoptotic action, most likely by a PI3K-independent reduction of autophagy. Complexes (1) and (2) interact in vitro with calf thymus DNA by an intercalative binding mode. EPR data indicated that 1 and 2 interact with human serum albumin (HSA) forming mixed ligand species.


Assuntos
Adenocarcinoma/tratamento farmacológico , Complexos de Coordenação/administração & dosagem , Cobre/administração & dosagem , Neoplasias Pulmonares/tratamento farmacológico , Adenocarcinoma/química , Adenocarcinoma de Pulmão , Antineoplásicos/administração & dosagem , Antineoplásicos/química , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Complexos de Coordenação/química , Cobre/química , DNA/química , Fibroblastos/efeitos dos fármacos , Flavanonas/administração & dosagem , Flavanonas/química , Hesperidina/administração & dosagem , Hesperidina/química , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Humanos , Neoplasias Pulmonares/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA